Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
They include patients who are candidates to complete concurrent treatment with endocavitary
brachytherapy External radiation therapy + more QT based weekly cisplatin.
Phase:
Phase 2
Details
Lead Sponsor:
Laboratorio Elea Phoenix S.A. Laboratorio Elea S.A.C.I.F. y A.